Posts Tagged ‘High’
High dietary iron linked to heart disease in women with diabetes.(Clinical Rounds): An article from: Skin & Allergy News
High dietary iron linked to heart disease in women with diabetes.(Clinical Rounds): An article from: Skin & Allergy News
This digital document is an article from Skin & Allergy News, published by Thomson Gale on March 1, 2007. The length of the article is 469 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: High dietary iron linked to heart disease in women with diabetes.(Clinical Rounds)
Author: Doug Brunk
Publication: Skin & Allergy News (Magazine/Journal)
Date: March 1, 2007
Publisher: Thomson Gale
Volume: 38 Issue: 3 Page: 70(1)
Distributed by Thomson Gale
List Price: $ 9.95
Price: $ 9.95
Mediven Elegance 16-20mmHg Thigh High Women’s Stockings – CLOSEOUT Color: Beige (0), Size: Medium
Mediven Elegance 16-20mmHg Thigh High Women’s Stockings – CLOSEOUT Color: Beige (0), Size: Medium
- **Innovative MediSilk yarn for maximum sheerness, softness and resiliency. Safe to machine wash and tumble dry.
- **Reciprocating knit heel and toe for added durability
- **Offset toe seam for added comfort
- **Flat, non-irritating seams
- **Sheer, resilient uncoated spandex (elasthan)
Mediven Elegance 16-20 mmHg Thigh High Stockings (Closed Toe). Find relief today with Mediven Elegance. Please note that the Mediven Elegance line has been discontinued by the manufacturer, and we have purchased all remaining stock directly from the Mediven. When this deal is gone, it’s gone, so stock up today! Quantities are limited. In the unlikely event that you purchase a product that has been sold out, we will contact you and offer either a refund or alternate substitution. Due to the closeout nature of this sale, ALL SALES ARE FINAL and NO RETURNS WILL BE ACCEPTED.
List Price: $ 55.98
Price: $ 44.00
CHOLESTEROL LOWERING IN DIABETES: New evidence supports aggressive LDL-C targets Recent guidelines categorize diabetes as a coronary heart disease … high LDL-C levels. (Postgraduate Medicine)
CHOLESTEROL LOWERING IN DIABETES: New evidence supports aggressive LDL-C targets Recent guidelines categorize diabetes as a coronary heart disease … high LDL-C levels. (Postgraduate Medicine)
Recent guidelines for treating patients with diabetes categorize the disorder as a coronary heart disease (CHD) equivalent and urge aggressive treatment of modifiable risk factors, such as plasma levels of low-density lipoprotein cholesterol (LDL-C). In this article, Dr Rosenson discusses the rationale for cholesterol lowering in patients with diabetes, the lipoprotein abnormalities that accompany insulin resistance, and the prognostic significance of high LDL particle numbers. He also highlights major findings from recent clinical trials to explore statin therapy and other treatment strategies for lowering lipoprotein levels in this patient population.
List Price: $ 9.99
Price: $ 9.99